DCF — GILA REGIONAL MEDICAL CENTER
Enterprise Value: $-58.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-58.1M
Enterprise Value
$-20.1M
PV of Cash Flows
$-38.1M
PV of Terminal Value
$-61.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $86.1M | $-2.7M | -3.0% | $-6.4M | $-5.8M |
| Year 2 | $88.7M | $-1.9M | -2.0% | $-5.7M | $-4.7M |
| Year 3 | $91.3M | $-1.0M | -1.0% | $-4.9M | $-3.7M |
| Year 4 | $94.1M | $-0.6M | -1.0% | $-4.6M | $-3.1M |
| Year 5 | $96.9M | $-0.4M | -0.0% | $-4.5M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-58.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$83.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.036477962162628816
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5